Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 08, 2021

SELL
$14.07 - $17.3 $169,543 - $208,465
-12,050 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$16.62 - $18.94 $10,138 - $11,553
-610 Reduced 4.82%
12,050 $209,000
Q1 2021

Apr 14, 2021

BUY
$15.15 - $19.78 $188,481 - $246,082
12,441 Added 5680.82%
12,660 $219,000
Q1 2021

Apr 13, 2021

SELL
$15.15 - $19.78 $237,188 - $309,675
-15,656 Reduced 98.62%
219 $3,000
Q4 2020

Feb 08, 2021

BUY
$16.86 - $19.67 $606 - $708
36 Added 0.23%
15,875 $293,000
Q3 2020

Nov 12, 2020

BUY
$15.4 - $20.16 $2,587 - $3,386
168 Added 1.07%
15,839 $275,000
Q2 2020

Jul 22, 2020

BUY
$18.24 - $21.45 $17,692 - $20,806
970 Added 6.6%
15,671 $286,000
Q1 2020

May 22, 2020

BUY
$16.28 - $25.63 $73,960 - $116,437
4,543 Added 44.72%
14,701 $296,000
Q1 2020

May 13, 2020

SELL
$16.28 - $25.63 $163,988 - $258,170
-10,073 Reduced 49.79%
10,158 $23,000
Q4 2019

Feb 12, 2020

SELL
$19.57 - $23.52 $359,774 - $432,391
-18,384 Reduced 47.61%
20,231 $471,000
Q3 2019

Nov 07, 2019

BUY
$19.85 - $22.76 $77,196 - $88,513
3,889 Added 11.2%
38,615 $774,000
Q2 2019

Jul 19, 2019

BUY
$17.59 - $21.1 $176,392 - $211,590
10,028 Added 40.6%
34,726 $733,000
Q1 2019

May 14, 2019

SELL
$18.01 - $20.11 $108,546 - $121,202
-6,027 Reduced 19.62%
24,698 $497,000
Q4 2018

Feb 07, 2019

BUY
$17.44 - $21.53 $61,859 - $76,366
3,547 Added 13.05%
30,725 $564,000
Q3 2018

Nov 13, 2018

SELL
$19.97 - $21.96 $20,349 - $22,377
-1,019 Reduced 3.61%
27,178 $581,000
Q2 2018

Aug 08, 2018

SELL
$20.16 - $24.68 $387,132 - $473,930
-19,203 Reduced 40.51%
28,197 $606,000
Q1 2018

May 02, 2018

SELL
$20.31 - $24.95 $87,840 - $107,908
-4,325 Reduced 8.36%
47,400 $1.01 Million
Q4 2017

Feb 09, 2018

BUY
$20.99 - $23.89 $53,692 - $61,110
2,558 Added 5.2%
51,725 $1.19 Million
Q3 2017

Nov 03, 2017

BUY
$20.07 - $21.89 $87,766 - $95,724
4,373 Added 9.76%
49,167 $1.08 Million
Q2 2017

Aug 11, 2017

BUY
N/A
44,794
44,794 $946,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.83B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.